Hamilton Thorne Ltd (CVE:HTL) – Equities researchers at Beacon Securities issued their FY2017 EPS estimates for Hamilton Thorne in a research note issued to investors on Tuesday. Beacon Securities analyst D. Cooper anticipates that the company will post earnings of $0.01 per share for the year. Beacon Securities has a “Buy” rating on the stock. Beacon Securities also issued estimates for Hamilton Thorne’s FY2018 earnings at $0.03 EPS and FY2019 earnings at $0.03 EPS.
Separately, Bloom Burton reissued a “buy” rating on shares of Hamilton Thorne in a research report on Wednesday, October 25th.
Hamilton Thorne (CVE:HTL) last posted its quarterly earnings results on Tuesday, November 21st. The company reported C$0.01 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of C$0.01. Hamilton Thorne had a net margin of 10.14% and a return on equity of 16.18%.
In other news, Director Meg Moray Spencer sold 51,652 shares of the stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of C$0.64, for a total value of C$33,057.28.
Hamilton Thorne Company Profile
Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The Company offers Clinical lasers, Research lasers and Clinical Sperm Analysis Products.
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.